Bernard Boxerbaum

2.0k total citations
35 papers, 1.5k citations indexed

About

Bernard Boxerbaum is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Bernard Boxerbaum has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Infectious Diseases. Recurrent topics in Bernard Boxerbaum's work include Streptococcal Infections and Treatments (10 papers), Cystic Fibrosis Research Advances (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Bernard Boxerbaum is often cited by papers focused on Streptococcal Infections and Treatments (10 papers), Cystic Fibrosis Research Advances (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Bernard Boxerbaum collaborates with scholars based in United States and Thailand. Bernard Boxerbaum's co-authors include Michael R. Jacobs, Jerome Liebman, Jill E. Baley, Catherine Demko, Mary Jane Thomassen, Robert M. Kliegman, John O’Bell, Samuel J. Horwitz, Linda K. McDougal and Dave A. May and has published in prestigious journals such as Circulation, PEDIATRICS and Annals of Neurology.

In The Last Decade

Bernard Boxerbaum

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Boxerbaum United States 17 776 511 400 357 216 35 1.5k
J. Owen Hendley United States 28 873 1.1× 317 0.6× 278 0.7× 422 1.2× 232 1.1× 65 2.0k
André Fleer Netherlands 29 1.4k 1.8× 545 1.1× 648 1.6× 485 1.4× 293 1.4× 51 2.5k
Carl Kamme Sweden 22 552 0.7× 302 0.6× 202 0.5× 265 0.7× 250 1.2× 54 1.3k
R. Doug Hardy United States 24 1.2k 1.6× 336 0.7× 352 0.9× 605 1.7× 538 2.5× 43 1.9k
Mirjana Nesin United States 27 745 1.0× 316 0.6× 539 1.3× 489 1.4× 186 0.9× 54 1.8k
Dieter W. Gump United States 23 417 0.5× 166 0.3× 191 0.5× 169 0.5× 267 1.2× 55 1.3k
Darwin L. Palmer United States 22 638 0.8× 226 0.4× 159 0.4× 534 1.5× 57 0.3× 50 2.0k
Alan E. Gober United States 20 427 0.6× 258 0.5× 317 0.8× 311 0.9× 116 0.5× 38 1.0k
P Grönroos Finland 21 590 0.8× 132 0.3× 151 0.4× 188 0.5× 361 1.7× 55 1.3k
Kenneth L. Vosti United States 20 573 0.7× 100 0.2× 299 0.7× 183 0.5× 92 0.4× 58 1.4k

Countries citing papers authored by Bernard Boxerbaum

Since Specialization
Citations

This map shows the geographic impact of Bernard Boxerbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Boxerbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Boxerbaum more than expected).

Fields of papers citing papers by Bernard Boxerbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Boxerbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Boxerbaum. The network helps show where Bernard Boxerbaum may publish in the future.

Co-authorship network of co-authors of Bernard Boxerbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Boxerbaum. A scholar is included among the top collaborators of Bernard Boxerbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Boxerbaum. Bernard Boxerbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heggie, Alfred D., et al.. (2001). Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. The Pediatric Infectious Disease Journal. 20(9). 854–859. 41 indexed citations
2.
Heggie, Alfred D., et al.. (1995). . The Journal of Pediatrics. 126(3). 503–504. 2 indexed citations
4.
Reichler, M. R., Robert F. Breiman, John R. Schreiber, et al.. (1992). The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio. The Journal of Infectious Diseases. 166(6). 1346–1353. 332 indexed citations
5.
Heggie, Alfred D., et al.. (1992). Prevalence and Characteristics of Pharyngeal Group A  -Hemolytic Streptococci in US Navy Recruits Receiving Benzathine Penicillin Prophylaxis. The Journal of Infectious Diseases. 166(5). 1006–1013. 12 indexed citations
6.
Boxerbaum, Bernard, et al.. (1988). Prevalence and significance of methicillin‐resistant stapHylococcus aureus in patients with cystic fibrosis. Pediatric Pulmonology. 4(3). 159–163. 49 indexed citations
7.
Pittard, William B., et al.. (1985). Bacteriostatic qualities of human milk. The Journal of Pediatrics. 107(2). 240–243. 17 indexed citations
8.
Klein, Bruce L., Bernard Boxerbaum, & Stephen C. Aronoff. (1985). Hemophilus influenzae type f meningitis in an adolescent. Pediatric Emergency Care. 1(3). 145–146. 6 indexed citations
9.
Hare, George F. Van, Giora Ben‐Shachar, Jerome Liebman, Bernard Boxerbaum, & Thomas A. Riemenschneider. (1984). Infective endocarditis in infants and children during the past 10 years: A decade of change. American Heart Journal. 107(6). 1235–1240. 76 indexed citations
10.
Boxerbaum, Bernard. (1981). Prevention of Streptococcal Neurosis. Primary Care Clinics in Office Practice. 8(4). 583–591. 2 indexed citations
11.
Boxerbaum, Bernard. (1980). Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. The Journal of Pediatrics. 96(4). 689–691. 65 indexed citations
12.
Thomassen, Mary Jane, Catherine Demko, Robert E. Wood, et al.. (1980). Ultrastructure and Function of Alveolar Macrophages from Cystic Fibrosis Patients. Pediatric Research. 14(5). 715–721. 50 indexed citations
13.
Heymann, Walter, Bernard Boxerbaum, & Sudesh P. Makker. (1980). Value of antistreptolysin "O" titers for differential diagnosis of renal diseases.. PubMed. 1(1). 4–9.
14.
Thomassen, Mary Jane, et al.. (1979). Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis. The Journal of Infectious Diseases. 140(6). 873–880. 119 indexed citations
15.
Boxerbaum, Bernard, et al.. (1975). Thiabendazole Treatment of Presumptive Visceral Larva Migrans (VLM). Clinical Pediatrics. 14(2). 147–150. 3 indexed citations
16.
Tafari, Nebiat, et al.. (1974). Needle Aspiration in Hemophilus influenzae Type b Cellulitis. PEDIATRICS. 54(4). 504–506. 27 indexed citations
17.
Boxerbaum, Bernard, et al.. (1973). Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.. PubMed. 108(4). 777–83. 29 indexed citations
18.
Boxerbaum, Bernard, et al.. (1972). Long-Term Prognosis of Rheumatic Fever Patients Receiving Regular Intramuscular Benzathine Penicillin. Circulation. 45(3). 543–551. 114 indexed citations
19.
Levine, Michael S., Bernard Boxerbaum, & Alfred D. Heggie. (1970). Recrudescence of H. Influenzae Meningitis after Therapy with Ampicillin. Clinical Pediatrics. 9(1). 54–57. 5 indexed citations
20.
Mortimer, Edward A. & Bernard Boxerbaum. (1965). Diagnosis and treatment: group A streptococcal infections.. PubMed. 36(6). 930–2. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026